Programs & Services
Talecris continues to expand its range of innovative programs and services to better meet the needs of our customers.
| Talecris Direct™ |
 |
Talecris Direct™ is a unique delivery service designed to help patients get the medicine they need, when and where they need it. With Talecris Direct™, a patient's medication goes wherever the patient goes.
www.talecrisdirect.com
|
| Precision Pharma Services |
 |
Precision Pharma offers development, manufacturing, packaging, and testing services for clinical, small-scale, and commercial-stage products — specializing in sterile pharmaceutical, biopharmaceutical, and complex biological finished products.
www.precisionpharma.com
|
| Talecris Plasma Resources |
 |
Talecris Plasma Resources, Inc. (TPR) is a newly formed company specializing in the collection of human plasma. Because human plasma is used to manufacture therapies that save and extend people's lives, Talecris Plasma Resources has an uncompromising commitment to quality and strict adherence to all regulations and guidelines governing plasma collection.
www.talecrisplasma.com
|
| Talecris Talents Grant Program |
 |
The Talecris New Trials Support (Talents) program is an initiative supporting investigator-initiated trials conceived by researchers and clinicians with an interest in intravenous immunoglobulin (IGIV) therapies. Each year, Talecris pledges $1 million to fund basic science and clinical research projects in various fields, including immunology, hematology, and neurology.
www.talecristalents.com
|
Important Safety Information
Thrombate III therapy has demonstrated a low occurrence of side effects. In clinical studies with Thrombate III, the most common side effects were dizziness, chest tightness, nausea, and a foul taste in the mouth. As with all plasma-derived therapeutics, the potential to transmit infectious agents, such as viruses, cannot be totally eliminated. Individuals who receive infusions of blood or blood plasma may develop signs and/or symptoms of some viral infections, particularly hepatitis C.
Please see full Prescribing Information for Thrombate III.
|